 | • レポートコード：20QY06-04321 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、リポソームドラッグデリバリーのグローバル市場について種類別（リポソームドキソルビシン、リポソームアンフォテラシンB、リポソームパクリタキセル、その他）、用途別（真菌感染症治療、がん・腫瘍治療、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・リポソームドラッグデリバリー市場の概要 ・世界の主要地域別リポソームドラッグデリバリー市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のリポソームドラッグデリバリー市場規模2015-2026：種類別（リポソームドキソルビシン、リポソームアンフォテラシンB、リポソームパクリタキセル、その他） ・世界のリポソームドラッグデリバリー市場規模2015-2026：用途別（真菌感染症治療、がん・腫瘍治療、その他） ・リポソームドラッグデリバリーの北米市場規模2015-2020 ・リポソームドラッグデリバリーのヨーロッパ市場規模2015-2020 ・リポソームドラッグデリバリーの中国市場規模2015-2020 ・リポソームドラッグデリバリーの日本市場規模2015-2020 ・リポソームドラッグデリバリーの東南アジア市場規模2015-2020 ・リポソームドラッグデリバリーのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Gilead Sciences、Pacira、Sun Pharmaceutical、Johnson & Johnson、Luye Pharma、Sigma-Tau Group、Ipsen (Onivyde)、CSPC、Teva Pharmaceutical、Novartis、Fudan-Zhangjiang） ・リポソームドラッグデリバリーの製造コスト分析 ・販売チャネル、流通業者、顧客 ・リポソームドラッグデリバリーの市場動向・機会・課題 ・調査の結論 |
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2018, the global revenue of Liposomes Drug Delivery market is nearly 2.30 billion USD.
Market Analysis and Insights: Global Liposomes Drug Delivery Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Liposomes Drug Delivery market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Liposomes Drug Delivery industry.
Based on our recent survey, we have several different scenarios about the Liposomes Drug Delivery YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 3350.6 million in 2019. The market size of Liposomes Drug Delivery will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Liposomes Drug Delivery Scope and Market Size
The global Liposomes Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Liposomes Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Liposomes Drug Delivery market is segmented into
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application, the Liposomes Drug Delivery market is segmented into
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
The Liposomes Drug Delivery market is analysed and market size information is provided by regions (countries). Segment by Application, the Liposomes Drug Delivery market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Liposomes Drug Delivery Market Share Analysis
Liposomes Drug Delivery market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Liposomes Drug Delivery business, the date to enter into the Liposomes Drug Delivery market, Liposomes Drug Delivery product introduction, recent developments, etc.
The major vendors covered:
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
1 Liposomes Drug Delivery Market Overview
1.1 Liposomes Drug Delivery Product Scope
1.2 Liposomes Drug Delivery Segment by Type
1.2.1 Global Liposomes Drug Delivery Sales by Type (2020-2026)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposomes Drug Delivery Segment by Application
1.3.1 Global Liposomes Drug Delivery Sales Comparison by Application (2020-2026)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Liposomes Drug Delivery Market Estimates and Forecasts (2015-2026)
1.4.1 Global Liposomes Drug Delivery Sales Growth Rate (2015-2026)
1.4.2 Global Liposomes Drug Delivery Revenue and Growth Rate (2015-2026)
1.4.3 Global Liposomes Drug Delivery Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Liposomes Drug Delivery Industry Impact
1.5.1 How the Covid-19 is Affecting the Liposomes Drug Delivery Industry
1.5.1.1 Liposomes Drug Delivery Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Liposomes Drug Delivery Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Liposomes Drug Delivery Players to Combat Covid-19 Impact
2 Liposomes Drug Delivery Estimate and Forecast by Region
2.1 Global Liposomes Drug Delivery Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Liposomes Drug Delivery Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Liposomes Drug Delivery Sales Market Share by Region (2015-2020)
2.2.2 Global Liposomes Drug Delivery Revenue Market Share by Region (2015-2020)
2.3 Global Liposomes Drug Delivery Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Liposomes Drug Delivery Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Liposomes Drug Delivery Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Liposomes Drug Delivery Estimates and Projections (2015-2026)
2.4.2 Europe Liposomes Drug Delivery Estimates and Projections (2015-2026)
2.4.3 China Liposomes Drug Delivery Estimates and Projections (2015-2026)
2.4.4 Japan Liposomes Drug Delivery Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Liposomes Drug Delivery Estimates and Projections (2015-2026)
2.4.6 India Liposomes Drug Delivery Estimates and Projections (2015-2026)
3 Global Liposomes Drug Delivery Competition Landscape by Players
3.1 Global Top Liposomes Drug Delivery Players by Sales (2015-2020)
3.2 Global Top Liposomes Drug Delivery Players by Revenue (2015-2020)
3.3 Global Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomes Drug Delivery as of 2019)
3.4 Global Liposomes Drug Delivery Average Price by Company (2015-2020)
3.5 Manufacturers Liposomes Drug Delivery Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Liposomes Drug Delivery Players (Opinion Leaders)
4 Global Liposomes Drug Delivery Market Size by Type
4.1 Global Liposomes Drug Delivery Historic Market Review by Type (2015-2020)
4.1.1 Global Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
4.1.2 Global Liposomes Drug Delivery Revenue Market Share by Type (2015-2020)
4.1.3 Global Liposomes Drug Delivery Price by Type (2014-2020)
4.2 Global Liposomes Drug Delivery Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Liposomes Drug Delivery Sales Forecast by Type (2021-2026)
4.2.2 Global Liposomes Drug Delivery Revenue Forecast by Type (2021-2026)
4.2.3 Global Liposomes Drug Delivery Price Forecast by Type (2021-2026)
5 Global Liposomes Drug Delivery Market Size by Application
5.1 Global Liposomes Drug Delivery Historic Market Review by Application (2015-2020)
5.1.1 Global Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
5.1.2 Global Liposomes Drug Delivery Revenue Market Share by Application (2015-2020)
5.1.3 Global Liposomes Drug Delivery Price by Application (2015-2020)
5.2 Global Liposomes Drug Delivery Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Liposomes Drug Delivery Sales Forecast by Application (2021-2026)
5.2.2 Global Liposomes Drug Delivery Revenue Forecast by Application (2021-2026)
5.2.3 Global Liposomes Drug Delivery Price Forecast by Application (2021-2026)
3 North America Liposomes Drug Delivery Market Facts & Figures
3.2 North America Liposomes Drug Delivery Sales Market Share by Company (2015-2020)
3.3 North America Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
3.4 North America Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
4 Europe Liposomes Drug Delivery Market Facts & Figures
4.2 Europe Liposomes Drug Delivery Sales Market Share by Company (2015-2020)
4.3 Europe Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
4.4 Europe Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
5 China Liposomes Drug Delivery Market Facts & Figures
5.2 China Liposomes Drug Delivery Sales Market Share by Company (2015-2020)
5.3 China Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
5.4 China Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
6 Japan Liposomes Drug Delivery Market Facts & Figures
6.2 Japan Liposomes Drug Delivery Sales Market Share by Company (2015-2020)
6.3 Japan Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
6.4 Japan Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
7 Southeast Asia Liposomes Drug Delivery Market Facts & Figures
7.2 Southeast Asia Liposomes Drug Delivery Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
8 India Liposomes Drug Delivery Market Facts & Figures
8.2 India Liposomes Drug Delivery Sales Market Share by Company (2015-2020)
8.3 India Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
8.4 India Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Liposomes Drug Delivery Business
12.1 Gilead Sciences
12.1.1 Gilead Sciences Liposomes Drug Delivery Corporation Information
12.1.2 Gilead Sciences Liposomes Drug Delivery Business Overview and Total Revenue
12.1.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Gilead Sciences Liposomes Drug Delivery Products Offered
12.1.5 Gilead Sciences Recent Development
12.2 Pacira
12.2.1 Pacira Liposomes Drug Delivery Corporation Information
12.2.2 Pacira Liposomes Drug Delivery Business Overview and Total Revenue
12.2.3 Pacira Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pacira Liposomes Drug Delivery Products Offered
12.2.5 Pacira Recent Development
12.3 Sun Pharmaceutical
12.3.1 Sun Pharmaceutical Liposomes Drug Delivery Corporation Information
12.3.2 Sun Pharmaceutical Liposomes Drug Delivery Business Overview and Total Revenue
12.3.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sun Pharmaceutical Liposomes Drug Delivery Products Offered
12.3.5 Sun Pharmaceutical Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Liposomes Drug Delivery Corporation Information
12.4.2 Johnson & Johnson Liposomes Drug Delivery Business Overview and Total Revenue
12.4.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Johnson & Johnson Liposomes Drug Delivery Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Luye Pharma
12.5.1 Luye Pharma Liposomes Drug Delivery Corporation Information
12.5.2 Luye Pharma Liposomes Drug Delivery Business Overview and Total Revenue
12.5.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Luye Pharma Liposomes Drug Delivery Products Offered
12.5.5 Luye Pharma Recent Development
12.6 Sigma-Tau Group
12.6.1 Sigma-Tau Group Liposomes Drug Delivery Corporation Information
12.6.2 Sigma-Tau Group Liposomes Drug Delivery Business Overview and Total Revenue
12.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sigma-Tau Group Liposomes Drug Delivery Products Offered
12.6.5 Sigma-Tau Group Recent Development
12.7 Ipsen (Onivyde)
12.7.1 Ipsen (Onivyde) Liposomes Drug Delivery Corporation Information
12.7.2 Ipsen (Onivyde) Liposomes Drug Delivery Business Overview and Total Revenue
12.7.3 Ipsen (Onivyde) Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Ipsen (Onivyde) Liposomes Drug Delivery Products Offered
12.7.5 Ipsen (Onivyde) Recent Development
12.8 CSPC
12.8.1 CSPC Liposomes Drug Delivery Corporation Information
12.8.2 CSPC Liposomes Drug Delivery Business Overview and Total Revenue
12.8.3 CSPC Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.8.4 CSPC Liposomes Drug Delivery Products Offered
12.8.5 CSPC Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Liposomes Drug Delivery Corporation Information
12.9.2 Teva Pharmaceutical Liposomes Drug Delivery Business Overview and Total Revenue
12.9.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Teva Pharmaceutical Liposomes Drug Delivery Products Offered
12.9.5 Teva Pharmaceutical Recent Development
12.10 Novartis
12.10.1 Novartis Liposomes Drug Delivery Corporation Information
12.10.2 Novartis Liposomes Drug Delivery Business Overview and Total Revenue
12.10.3 Novartis Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis Liposomes Drug Delivery Products Offered
12.10.5 Novartis Recent Development
12.11 Fudan-Zhangjiang
12.11.1 Fudan-Zhangjiang Liposomes Drug Delivery Corporation Information
12.11.2 Fudan-Zhangjiang Liposomes Drug Delivery Business Overview and Total Revenue
12.11.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Fudan-Zhangjiang Liposomes Drug Delivery Products Offered
12.11.5 Fudan-Zhangjiang Recent Development
13 Liposomes Drug Delivery Manufacturing Cost Analysis
13.1 Liposomes Drug Delivery Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Liposomes Drug Delivery
13.4 Liposomes Drug Delivery Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Liposomes Drug Delivery Distributors List
14.3 Liposomes Drug Delivery Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Liposomes Drug Delivery Sales (K Vial) Growth Rate by Type (2020-2026)
Table 2. Global Liposomes Drug Delivery Sales (K Vial) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Liposomes Drug Delivery Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Liposomes Drug Delivery Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Liposomes Drug Delivery Players to Combat Covid-19 Impact
Table 8. Global Market Liposomes Drug Delivery Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Liposomes Drug Delivery Sales (K Vial) by Region (2015-2020)
Table 10. Global Liposomes Drug Delivery Sales Market Share by Region (2015-2020)
Table 11. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Liposomes Drug Delivery Revenue Share by Region (2015-2020)
Table 13. Global Liposomes Drug Delivery Sales (K Vial) Forecast by Region (2021-2026)
Table 14. Global Liposomes Drug Delivery Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Liposomes Drug Delivery Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Liposomes Drug Delivery Revenue Share Forecast by Region (2021-2026)
Table 17. Global Liposomes Drug Delivery (K Vial) of Key Companies (2015-2020)
Table 18. Global Liposomes Drug Delivery Sales Share by Company (2015-2020)
Table 19. Global Liposomes Drug Delivery Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Liposomes Drug Delivery Revenue Share by Company (2015-2020)
Table 21. Global Liposomes Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomes Drug Delivery as of 2019)
Table 22. Global Liposomes Drug Delivery Average Price (USD/Vial) of Key Company (2015-2020)
Table 23. Manufacturers Liposomes Drug Delivery Manufacturing Sites and Area Served
Table 24. Manufacturers Liposomes Drug Delivery Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Liposomes Drug Delivery Players
Table 27. Global Liposomes Drug Delivery Sales (K Vial) by Type (2015-2020)
Table 28. Global Liposomes Drug Delivery Sales Share by Type (2015-2020)
Table 29. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Liposomes Drug Delivery Price (K Vial) by Type (2015-2020)
Table 31. Global Liposomes Drug Delivery Sales Share by Type (2021-2026)
Table 32. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Liposomes Drug Delivery Revenue Share by Type (2021-2026)
Table 34. Global Liposomes Drug Delivery Price (K Vial) by Type (2021-2026)
Table 35. Global Liposomes Drug Delivery Sales (K Vial) by Application (2015-2020)
Table 36. Global Liposomes Drug Delivery Sales Share by Application (2015-2020)
Table 37. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Liposomes Drug Delivery Price (K Vial) by Application (2015-2020)
Table 39. Global Liposomes Drug Delivery Sales (K Vial) by Application (2021-2026)
Table 40. Global Liposomes Drug Delivery Sales Share by Application (2021-2026)
Table 41. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Liposomes Drug Delivery Revenue Share by Application (2021-2026)
Table 43. Global Liposomes Drug Delivery Price (K Vial) by Application (2021-2026)
Table 44. United States Liposomes Drug Delivery Sales (K Vial) by Company (2015-2020)
Table 45. United States Liposomes Drug Delivery Sales Market Share by Company (2015-2020)
Table 46. United States Liposomes Drug Delivery Sales (K Vial) by Type (2015-2020)
Table 47. United States Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
Table 48. United States Liposomes Drug Delivery Sales (K Vial) by Application (2015-2020)
Table 49. United States Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
Table 50. Europe Liposomes Drug Delivery Sales (K Vial) by Company (2015-2020)
Table 51. Europe Liposomes Drug Delivery Sales Market Share by Company (2015-2020)
Table 52. Europe Liposomes Drug Delivery Sales (K Vial) by Type (2015-2020)
Table 53. Europe Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
Table 54. Europe Liposomes Drug Delivery Sales (K Vial) by Application (2015-2020)
Table 55. Europe Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
Table 56. China Liposomes Drug Delivery Sales (K Vial) by Company (2015-2020)
Table 57. China Liposomes Drug Delivery Sales Market Share by Company (2015-2020)
Table 58. China Liposomes Drug Delivery Sales (K Vial) by Type (2015-2020)
Table 59. China Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
Table 60. China Liposomes Drug Delivery Sales (K Vial) by Application (2015-2020)
Table 61. China Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
Table 62. Japan Liposomes Drug Delivery Sales (K Vial) by Company (2015-2020)
Table 63. Japan Liposomes Drug Delivery Sales Market Share by Company (2015-2020)
Table 64. Japan Liposomes Drug Delivery Sales (K Vial) by Type (2015-2020)
Table 65. Japan Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
Table 66. Japan Liposomes Drug Delivery Sales (K Vial) by Application (2015-2020)
Table 67. Japan Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Liposomes Drug Delivery Sales (K Vial) by Company (2015-2020)
Table 69. Southeast Asia Liposomes Drug Delivery Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Liposomes Drug Delivery Sales (K Vial) by Type (2015-2020)
Table 71. Southeast Asia Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Liposomes Drug Delivery Sales (K Vial) by Type (2015-2020)
Table 73. Southeast Asia Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
Table 74. India Liposomes Drug Delivery Sales (K Vial) by Company (2015-2020)
Table 75. India Liposomes Drug Delivery Sales Market Share by Company (2015-2020)
Table 76. India Liposomes Drug Delivery Sales (K Vial) by Type (2015-2020)
Table 77. India Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
Table 78. India Liposomes Drug Delivery Sales (K Vial) by Application (2015-2020)
Table 79. India Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
Table 80. Gilead Sciences Corporation Information
Table 81. Gilead Sciences Description and Business Overview
Table 82. Gilead Sciences Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 83. Gilead Sciences Liposomes Drug Delivery Product
Table 84. Gilead Sciences Recent Development
Table 85. Pacira Corporation Information
Table 86. Pacira Description and Business Overview
Table 87. Pacira Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 88. Pacira Liposomes Drug Delivery Product
Table 89. Pacira Recent Development
Table 90. Sun Pharmaceutical Corporation Information
Table 91. Sun Pharmaceutical Description and Business Overview
Table 92. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 93. Sun Pharmaceutical Liposomes Drug Delivery Product
Table 94. Sun Pharmaceutical Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Liposomes Drug Delivery Product
Table 99. Johnson & Johnson Recent Development
Table 100. Luye Pharma Corporation Information
Table 101. Luye Pharma Description and Business Overview
Table 102. Luye Pharma Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 103. Luye Pharma Liposomes Drug Delivery Product
Table 104. Luye Pharma Recent Development
Table 105. Sigma-Tau Group Corporation Information
Table 106. Sigma-Tau Group Description and Business Overview
Table 107. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 108. Sigma-Tau Group Liposomes Drug Delivery Product
Table 109. Sigma-Tau Group Recent Development
Table 110. Ipsen (Onivyde) Corporation Information
Table 111. Ipsen (Onivyde) Description and Business Overview
Table 112. Ipsen (Onivyde) Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 113. Ipsen (Onivyde) Liposomes Drug Delivery Product
Table 114. Ipsen (Onivyde) Recent Development
Table 115. CSPC Corporation Information
Table 116. CSPC Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 117. CSPC Description and Business Overview
Table 118. CSPC Liposomes Drug Delivery Product
Table 119. CSPC Recent Development
Table 120. Teva Pharmaceutical Corporation Information
Table 121. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 122. Teva Pharmaceutical Description and Business Overview
Table 123. Teva Pharmaceutical Liposomes Drug Delivery Product
Table 124. Teva Pharmaceutical Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 128. Novartis Liposomes Drug Delivery Product
Table 129. Novartis Recent Development
Table . Fudan-Zhangjiang Corporation Information
Table . Fudan-Zhangjiang Description and Business Overview
Table . Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table . Fudan-Zhangjiang Liposomes Drug Delivery Product
Table . Fudan-Zhangjiang Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Liposomes Drug Delivery Distributors List
Table 138. Liposomes Drug Delivery Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomes Drug Delivery Product Picture
Figure 2. Global Liposomes Drug Delivery Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Liposomes Drug Delivery Market Share by Application in 2020 & 2026
Figure 6. Fungal Infection Therapy Examples
Figure 7. Cancer & Tumor Therapy Examples
Figure 8. Others Examples
Figure 9. Global Liposomes Drug Delivery Sales (K Vial) Growth Rate (2015-2026)
Figure 10. Global Liposomes Drug Delivery Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Liposomes Drug Delivery Price Trends Growth Rate (2015-2026) (USD/Vial)
Figure 12. Global Liposomes Drug Delivery Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Liposomes Drug Delivery Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Liposomes Drug Delivery Sales (K Vial) Growth Rate (2015-2026)
Figure 16. Europe Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Liposomes Drug Delivery Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Liposomes Drug Delivery Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Liposomes Drug Delivery Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Liposomes Drug Delivery Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Liposomes Drug Delivery Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Liposomes Drug Delivery Players Market Share by Revenue in Liposomes Drug Delivery 2015 & 2019
Figure 27. Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Liposomes Drug Delivery Revenue Share by Type (2015-2020)
Figure 29. Global Liposomes Drug Delivery Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Liposomes Drug Delivery Revenue Share by Application (2015-2020)
Figure 31. Global Liposomes Drug Delivery Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Liposomes Drug Delivery Sales Market Share by Type in 2019
Figure 33. United States Liposomes Drug Delivery Sales Market Share by Type in 2019
Figure 34. Europe Liposomes Drug Delivery Sales Market Share by Company in 2019
Figure 35. Europe Liposomes Drug Delivery Sales Market Share by Type in 2019
Figure 36. Europe Liposomes Drug Delivery Sales Market Share by Application in 2019
Figure 37. China Liposomes Drug Delivery Sales Market Share by Company in 2019
Figure 38. China Liposomes Drug Delivery Sales Market Share by Type in 2019
Figure 39. China Liposomes Drug Delivery Sales Market Share by Application in 2019
Figure 40. Japan Liposomes Drug Delivery Sales Market Share by Company in 2019
Figure 41. Japan Liposomes Drug Delivery Sales Market Share by Type in 2019
Figure 42. Japan Liposomes Drug Delivery Sales Market Share by Application in 2019
Figure 43. Southeast Asia Liposomes Drug Delivery Sales Market Share by Company in 2019
Figure 44. Southeast Asia Liposomes Drug Delivery Sales Market Share by Type in 2019
Figure 45. Southeast Asia Liposomes Drug Delivery Sales Market Share by Application in 2019
Figure 46. India Liposomes Drug Delivery Sales Market Share by Company in 2019
Figure 47. India Liposomes Drug Delivery Sales Market Share by Type in 2019
Figure 48. India Liposomes Drug Delivery Sales Market Share by Application in 2019
Figure 49. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pacira Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Luye Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Sigma-Tau Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Ipsen (Onivyde) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. CSPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Fudan-Zhangjiang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Liposomes Drug Delivery
Figure 62. Manufacturing Process Analysis of Liposomes Drug Delivery
Figure 63. Liposomes Drug Delivery Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
ドラッグデリバリーにおけるナノテクノロジーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Nanotechnology in Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8% in the forecast period of 2020 to 2025 and will expected to reach USD 8000.6 million by 2025, from USD 6153.4 million in 2019. The Nano…- リポソームの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Liposomes market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Liposomes market report provides a …
- 注射可能型ドラッグデリバリーデバイスの世界市場レポート2020 Injectable drug delivery devices are the devices used to administer drugs into the circulatory system. It is the most effective and common route for the administration of most therapeutic agents to ensure a quick response. Injectable drugs are used when patient is unconscious and require quick effec…
- ドラッグデリバリースマートピルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drug-delivery Smart Pill market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drug-delivery Smart …
- 経口ドラッグデリバリーの世界市場レポート2020 Market Analysis and Insights: Global Oral Drug Delivery Market The global Oral Drug Delivery market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Oral Drug Delivery Scope and Market Size The global Oral Drug D…